Supposedly the beneficiary of the vaccine story as one of the appointees approved by the government. A duopoly with DPHARMA. However... their price & volume action is dimming fast..
The cup and handle pattern is invalidated.
The recent decision to prioritize Pfizer vaccine over Sinovac really trigger a sell-down on PHARMA stock price with high volume. Expect continued selling in the coming days.
https://www.straitstimes.com/asia/se-asia/malaysias-kelantan-opts-for-pfizer-biontech-covid-19-vaccine-over-sinovac-other-states
The rest of the vaccine related stock hype: Kanger, Solution, HWGB, Yongtai, Bintai , yet to see any new development as the government controlled tightly the distribution and sale of vaccine to the public from third parties.
Disclaimer
This information only serves as reference information and does not constitute a buy or sell call. Conduct your own research and assessment before deciding to buy or sell any stock
The cup and handle pattern is invalidated.
The recent decision to prioritize Pfizer vaccine over Sinovac really trigger a sell-down on PHARMA stock price with high volume. Expect continued selling in the coming days.
https://www.straitstimes.com/asia/se-asia/malaysias-kelantan-opts-for-pfizer-biontech-covid-19-vaccine-over-sinovac-other-states
The rest of the vaccine related stock hype: Kanger, Solution, HWGB, Yongtai, Bintai , yet to see any new development as the government controlled tightly the distribution and sale of vaccine to the public from third parties.
Disclaimer
This information only serves as reference information and does not constitute a buy or sell call. Conduct your own research and assessment before deciding to buy or sell any stock